ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,005,000 | +46.6% | 850,000 | +70.0% | 0.40% | +45.2% |
| Q1 2019 | $6,825,000 | +232.9% | 500,000 | +150.0% | 0.28% | +267.1% |
| Q4 2018 | $2,050,000 | -64.2% | 200,000 | -60.0% | 0.08% | -11.6% |
| Q4 2017 | $5,725,000 | -6.5% | 500,000 | 0.0% | 0.09% | -18.9% |
| Q3 2017 | $6,125,000 | +78.3% | 500,000 | +66.7% | 0.11% | +76.7% |
| Q2 2017 | $3,435,000 | -45.0% | 300,000 | 0.0% | 0.06% | -56.8% |
| Q1 2017 | $6,240,000 | – | 300,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |